The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The nutrient-sensitive kinase mammalian target of rapamycin (mTOR) and its downstream target S6 kinase (S6K) are involved in amino acid–induced insulin resistance. Whether the mTOR/S6K pathway directly modulates glucose metabolism in humans is unknown. We studied 11 healthy men (29 years old, BMI 23 kg/m2) twice in random order after oral administration of 6 mg rapamycin, a specific mTOR inhibitor, or placebo. An amino acid mixture was infused to activate mTOR, and somatostatin-insulin-glucose clamps created conditions of low peripheral hyperinsulinemia (∼100 pmol/l, 0–180 min) and prandial-like peripheral hyperinsulinemia (∼450 pmol/l, 180–360 min). Glucose turnover was assessed using d-[6,6-2H2]glucose infusion (n = 8). Skeletal muscle biopsies were performed at baseline and during prandial-like peripheral hyperinsulinemia (n = 3). At low peripheral hyperinsulinemia, whole-body glucose uptake was not affected by rapamycin. During prandial-like peripheral hyperinsulinemia, rapamycin increased glucose uptake compared with placebo by 17% (Rd|300–360 min, 75 ± 5 vs. 64 ± 5 μmol · kg−1 · min−1, P = 0.0008). Rapamycin affected endogenous glucose production neither at baseline nor during low or prandial-like peripheral hyperinsulinemia. Combined hyperaminoacidemia and prandial-like hyperinsulinemia increased S6K phosphorylation and inhibitory insulin receptor substrate-1 (IRS-1) phosphorylation at Ser312 and Ser636 in the placebo group. Rapamycin partially inhibited this increase in mTOR-mediated S6K phosphorylation and IRS-1 Ser312 and Ser636 phosphorylation. In conclusion, rapamycin stimulates insulin-mediated glucose uptake in man under conditions known to activate the mTOR/S6K pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [39]
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [39]
In the citing paper
“Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle [155,156].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In addition to polygenic predisposition, environmental factors including quality and quantity of food supply, dietary behavior, and physical activity are of major importance for the development of type 2 diabetes (4,5).”
BackgroundTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3×
“Recent reports indicate that the activity of the mTOR pathway is increased in rodent models of obesity and that mice deficient in S6 kinase (S6K), a downstream effector of mTOR, are protected against diet-induced insulin resistance (20,21).”
BackgroundMethodMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
Research works printed but not linked: 1
- Krebs M, Roden M: Nutrient-induced insulin resistance in human skeletal muscle. Curr Med Chem 11:901-908, 2004 · DOI · Paper page
Cited by
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Rapamycin: one drug, many effects
Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Copps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
“Similar human studies demonstrate the involvement of mTORC1 in these effects [114], as well as the stimulation by AA of IRS1 S1101 (mS1097) phosphorylation in muscle, likely by S6K1 [56].”
BackgroundSmith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665
The regulation and function of Class III PI3Ks: novel roles for Vps34
Backer, J. M. (2008) · Biochemical Journal · doi:10.1042/bj20071427 · Cited by 659
Phosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598
Greenhaff, P. L., Karagounis, L. G., Peirce, N., Simpson, E. J., Hazell, M., Layfield, R., Wackerhage, H., Smith, K., Atherton, P., Selby, A., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90411.2008 · Cited by 495
Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Polak, P., Cybulski, N., Feige, J. N., Auwerx, J., Rüegg, M. A., & Hall, M. N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.003 · Cited by 480
Drummond, M. J., Fry, C. S., Glynn, E. L., Dreyer, H. C., Dhanani, S., Timmerman, K. L., Volpi, E., & Rasmussen, B. B. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.163816 · Cited by 439
Tanti, J.-F., & Jager, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.004 · Cited by 430
Laferrère, B., Reilly, D., Arias, S., Swerdlow, N., Gorroochurn, P., Bawa, B., Bose, M., Teixeira, J., Stevens, R. D., Wenner, B. R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002043 · Cited by 384
Fraenkel, M., Ketzinel-Gilad, M., Ariav, Y., Pappo, O., Karaca, M., Castel, J., Berthault, M.-F., Magnan, C., Cerasi, E., Kaiser, N., et al. (2008) · Diabetes · doi:10.2337/db07-0922 · Cited by 380
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · Clinical Science · doi:10.1042/cs20100597 · Cited by 372
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
Rickels, M. R., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00154 · Cited by 329
Li, Y., Xu, S., Giles, A., Nakamura, K., Lee, J. W., Hou, X., Donmez, G., Li, J., Luo, Z., Walsh, K., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-173492 · Cited by 297
Vanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
AMPK and Exercise: Glucose Uptake and Insulin Sensitivity
O'Neill, H. M. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.1 · Cited by 295
“Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle [155,156].”
BackgroundLeucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways
Xiao, F., Huang, Z., Li, H., Yu, J., Wang, C., Chen, S., Meng, Q., Cheng, Y., Gao, X., Li, J., et al. (2011) · Diabetes · doi:10.2337/db10-1246 · Cited by 286
Perl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
Growth and aging: a common molecular mechanism
Blagosklonny, M. V., & Hall, M. N. (2009) · Aging · doi:10.18632/aging.100040 · Cited by 212
Rapamycin for longevity: opinion article
Blagosklonny, M. V. (2019) · Aging · doi:10.18632/aging.102355 · Cited by 205
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Self-citationTargeting ageing with rapamycin and its derivatives in humans: a systematic review
Lee, D. J. W., Hodzic Kuerec, A., & Maier, A. B. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00258-1 · Cited by 175
A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes
Park, S., Sadanala, K. C., & Kim, E.-K. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0126 · Cited by 168
Novel and Reversible Mechanisms of Smoking-Induced Insulin Resistance in Humans
Bergman, B. C., Perreault, L., Hunerdosse, D., Kerege, A., Playdon, M., Samek, A. M., & Eckel, R. H. (2012) · Diabetes · doi:10.2337/db12-0418 · Cited by 167
Ong, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
Izzo, C., Vitillo, P., Di Pietro, P., Visco, V., Strianese, A., Virtuoso, N., Ciccarelli, M., Galasso, G., Carrizzo, A., & Vecchione, C. (2021) · Life · doi:10.3390/life11010060 · Cited by 162
Testa, G., Biasi, F., Poli, G., & Chiarpotto, E. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660699 · Cited by 148
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
Komarova, E. A., Antoch, M. P., Novototskaya, L. R., Chernova, O. B., Paszkiewicz, G., Leontieva, O. V., Blagosklonny, M. V., & Gudkov, A. V. (2012) · Aging · doi:10.18632/aging.100498 · Cited by 146
AMPK exerts dual regulatory effects on the PI3K pathway
Tao, R., Gong, J., Luo, X., Zang, M., Guo, W., Wen, R., & Luo, Z. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-1 · Cited by 141
Leucine signaling in the pathogenesis of type 2 diabetes and obesity
Melnik, B. C. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i3.38 · Cited by 140
Apontes, P., Leontieva, O. V., Demidenko, Z. N., Li, F., & Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.248 · Cited by 149
mTOR: A Cellular Regulator Interface in Health and Disease
Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 137
Autophagy in Diabetic Retinopathy
Rosa, M. D., Distefano, G., Gagliano, C., Rusciano, D., & Malaguarnera, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160321122900 · Cited by 145
The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2
Yang, X., Yang, C., Farberman, A., Rideout, T. C., de Lange, C. F. M., France, J., & Fan, M. Z. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0567 · Cited by 128
Magkos, F., Bradley, D., Schweitzer, G. G., Finck, B. N., Eagon, J. C., Ilkayeva, O., Newgard, C. B., & Klein, S. (2013) · Diabetes · doi:10.2337/db13-0185 · Cited by 126
From causes of aging to death from COVID-19
Blagosklonny, M. V. (2020) · Aging · doi:10.18632/aging.103493 · Cited by 124
Gene expression analysis of mTOR pathway: association with human longevity
Passtoors, W. M., Beekman, M., Deelen, J., van der Breggen, R., Maier, A. B., Guigas, B., Derhovanessian, E., van Heemst, D., de Craen, A. J. M., Gunn, D. A., et al. (2013) · Aging Cell · doi:10.1111/acel.12015 · Cited by 122
Xiao, F., Yu, J., Guo, Y., Deng, J., Li, K., Du, Y., Chen, S., Zhu, J., Sheng, H., & Guo, F. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.006 · Cited by 132
Amyloid-beta and tau protein beyond Alzheimer’s disease
Abyadeh, M., Gupta, V., Paulo, J. A., Mahmoudabad, A. G., Shadfar, S., Mirshahvaladi, S., Gupta, V. B., Nguyen, C. T. O., Finkelstein, D. I., You, Y., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386406 · Cited by 133
Blagosklonny, M. V. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.506 · Cited by 116
Molecular Mechanisms of Muscle Plasticity with Exercise
Hoppeler, H., Baum, O., Lurman, G., & Mueller, M. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100042 · Cited by 111
Smith, G. I., Yoshino, J., Kelly, S. C., Reeds, D. N., Okunade, A., Patterson, B. W., Klein, S., & Mittendorfer, B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.047 · Cited by 111
Yang, S.-B., Lee, H. Y., Young, D. M., Tien, A.-C., Rowson-Baldwin, A., Shu, Y. Y., Jan, Y. N., & Jan, L. Y. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0834-3 · Cited by 103
Antagonistic control of muscle cell size by AMPK and mTORC1
Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Foretz, M., & Viollet, B. (2011) · Cell Cycle · doi:10.4161/cc.10.16.17102 · Cited by 100
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100461 · Cited by 88
mTORC1 signaling and regulation of pancreatic β-cell mass
Blandino-Rosano, M., Chen, A. Y., Scheys, J. O., Alejandro, E. U., Gould, A. P., Taranukha, T., Elghazi, L., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2012) · Cell Cycle · doi:10.4161/cc.20036 · Cited by 98
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives
Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100149 · Cited by 88
Vanweert, F., Neinast, M. D., Erazo‐Tapia, E., van de Weijer, T., Hoeks, J., Schrauwen‐Hinderling, V. B., Blair, M. C., Bornstein, M. R., Hesselink, M. K. C., Schrauwen, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31249-9 · Cited by 96
From rapalogs to anti-aging formula
Blagosklonny, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18033 · Cited by 83
Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
Kleinert, M., Sylow, L., Fazakerley, D. J., Krycer, J. R., Thomas, K. C., Oxbøll, A.-J., Jordy, A. B., Jensen, T. E., Yang, G., Schjerling, P., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.06.004 · Cited by 81
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
Kolosova, N. G., Muraleva, N. A., Александровна, Ж. А., Stefanova, N. A., Фурсова, А. Ж., & Blagosklonny, M. V. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.018 · Cited by 86
Du, C., Liu, W., Yang, J., Zhao, S.-S., & Liu, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.932670 · Cited by 90
Hormesis does not make sense except in the light of TOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100411 · Cited by 78
Leontieva, O. V., Paszkiewicz, G. M., & Blagosklonny, M. V. (2014) · Aging Cell · doi:10.1111/acel.12211 · Cited by 78
Muscle protein anabolism in type 2 diabetes
Bassil, M. S., & Gougeon, R. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835a88ee · Cited by 77
Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice
Liu, K. A., Lashinger, L. M., Rasmussen, A. J., & Hursting, S. D. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-6 · Cited by 89
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
Blagosklonny, M. V. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1822-8 · Cited by 74
Tzatsos, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027748 · Cited by 74
The role of mTOR in the adaptation and failure of β‐cells in type 2 diabetes
Leibowitz, G., Cerasi, E., & Ketzinel‐Gilad, M. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00952.x · Cited by 74
The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus
Suhara, T., Baba, Y., Shimada, B. K., Higa, J. K., & Matsui, T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0865-4 · Cited by 72
Chen, H., Nie, Q., Hu, J., Huang, X., Yin, J., & Nie, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07871 · Cited by 71
Leontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.178 · Cited by 68
Balage, M., Dupont, J., Mothe‐Satney, I., Tesseraud, S., Mosoni, L., & Dardevet, D. P. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.02.001 · Cited by 73
Blagosklonny, M. V. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0722 · Cited by 67
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Kezić, A., Popović, L., & Lalic, K. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2640342 · Cited by 72
Grote, C. W., Morris, J. K., Ryals, J. M., Geiger, P. C., & Wright, D. E. (2011) · Experimental Diabetes Research · doi:10.1155/2011/212571 · Cited by 66
Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent
Grzych, G., Vonghia, L., Bout, M.-A., Weyler, J., Verrijken, A., Dirinck, E. L., Curt, M. J.-C., Gaal, L. V., Paumelle, R., Francque, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa175 · Cited by 72
Post-Transplantation Diabetes Mellitus
Ahmed, S. H., Biddle, K., Augustine, T., & Azmi, S. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00790-5 · Cited by 77
Cellular and Molecular Pathophysiology of Gestational Diabetes
Torres‐Torres, J., Monroy-Muñoz, I. E., Duran, J. P., Solis‐Paredes, J. M., Camacho‐Martinez, Z. A., Baca, D., y Sosa, S. E., Martinez-Portilla, R. J., Rojas‐Zepeda, L., Borboa-Olivares, H. J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111641 · Cited by 89
Roland, M., Gatault, P., Doute, C., Büchler, M., Al-Najjar, A., Barbet, C., Chatelet, V., Marlière, J.-F., Nivet, H., Lebranchu, Y., et al. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00640.x · Cited by 63
Knebel, B., Strassburger, K., Szendroedi, J., Kotzka, J., Scheer, M., Nowotny, B., Müssig, K., Lehr, S., Pacini, G., Finner, H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4133 · Cited by 63
Self-citationThe Metabolite Profiles of the Obese Population Are Gender-Dependent
Xie, G., Ma, X., Zhao, A., Wang, C., Zhang, Y., Nieman, D. C., Nicholson, J. K., Jia, W. P., Bao, Y., & Jia, W. (2014) · Journal of Proteome Research · doi:10.1021/pr500434s · Cited by 73
Melnik, B. C., John, S. M., Carrera‐Bastos, P., & Cordain, L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-74 · Cited by 69
Rapamycin-Induced Glucose Intolerance: Hunger or Starvation Diabetes
Blagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18595 · Cited by 59
Fang, Y., Ma, J., Lei, P., Wang, L., Qu, J., Zhao, J., Liu, F., Yan, X., Wu, W., Jin, L., et al. (2023) · Foods · doi:10.3390/foods12020363 · Cited by 75
Rivas, D. A., Yaspelkis, B. B., Hawley, J. A., & Lessard, S. J. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0202 · Cited by 66
Nutrient Excess in AMPK Downregulation and Insulin Resistance.
Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2013) · PubMed · Cited by 78
Li, X. O., Wang, X., Liu, R., Ma, Y., Guo, H., Hao, L., Yao, P., Liu, L., Sun, X., He, K., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200311 · Cited by 64
Estimating insulin demand for protein-containing foods using the food insulin index
Bell, K. J., Gray, R., Munns, D., Petocz, P., Howard, G., Colagiuri, S., & Brand-Miller, J. C. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.126 · Cited by 61
Melnik, B. C. (2012) · Journal of Obesity · doi:10.1155/2012/197653 · Cited by 63
Mangge, H., Zelzer, S., Prüller, F., Schnedl, W. J., Weghuber, D., Enko, D., Bergsten, P., Haybaeck, J., & Meinitzer, A. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.007 · Cited by 61
Roles of mTOR in Diabetic Kidney Disease
Yasuda‒Yamahara, M., Kume, S., & Maegawa, H. (2021) · Antioxidants · doi:10.3390/antiox10020321 · Cited by 60
Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing
Bettedi, L., & Foukas, L. C. (2017) · Biogerontology · doi:10.1007/s10522-017-9724-6 · Cited by 53
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Andrada, P., Rotellar, F., Valentí, V., Moncada, R., Martí, P., Silva, C., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0632-9 · Cited by 59
Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis
Tobias, D. K., Mora, S., Verma, S., & Lawler, P. R. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000552 · Cited by 56
Anti-Aging Effects of Calorie Restriction (CR) and CR Mimetics Based on the Senoinflammation Concept
Kim, D. H., Bang, E., Jung, H. J., Noh, S. G., Yu, B. P., Choi, Y. J., & Chung, H. Y. (2020) · Nutrients · doi:10.3390/nu12020422 · Cited by 58
NCI's provocative questions on cancer: some answers to ignite discussion
Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.432 · Cited by 54
Wu, J., Zhou, S.-L., Pi, L.-H., Shi, X.-J., Ma, L.-R., Chen, Z., Qu, M.-L., Li, X., Nie, S.-D., Liao, D.-F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17257 · Cited by 50
Donati, A., Recchia, G., Cavallini, G., & Bergamini, E. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.6.550 · Cited by 50
The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake
Jiang, X., Kenerson, H. L., Aicher, L. D., Miyaoka, R. S., Eary, J. F., Bissler, J. J., & Yeung, R. S. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070958 · Cited by 53
β-Cell Secretory Capacity and Demand in Recipients of Islet, Pancreas, and Kidney Transplants
Rickels, M. R., Mueller, R., Teff, K. L., & Naji, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2289 · Cited by 48
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney
Pulakat, L., DeMarco, V. G., Whaley‐Connell, A. T., & Sowers, J. R. (2011) · Cardiorenal Medicine · doi:10.1159/000327140 · Cited by 49
Branched‐chain amino acids and the association with type 2 diabetes
Chen, X., & Yang, W. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12345 · Cited by 55
Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
Konopka, A. R., Lamming, D. W., RAP PAC Investigators, Grasso, B. A., Marrah, R. C., Decker, S., Garg, N., Park, Y., Lim, S. Y., Simcox, J., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00935-x · Cited by 49
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 58
Carunchio, I., Curcio, L., Pieri, M., Pica, F., Caioli, S., Viscomi, M. T., Molinari, M., Canu, N., Bernardi, G., & Zona, C. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.033 · Cited by 48
Gao, Z., Yin, J., Zhang, J., He, Q., McGuinness, O. P., & Ye, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007260 · Cited by 47
Metadata
- Authors
- Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., Bischof, M., & Roden, M.
- Affiliations
- Medical University of Vienna (AT)
- Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- Hanusch Hospital (AT)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 56
- Issue
- 6
- Pages
- 1600-1607
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2156080804
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 5 · 2023: 12 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 12 · 2015: 12 · 2014: 16 · 2013: 11 · 2012: 15
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk
- Österreichische Diabetes Gesellschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- mTOR, S6 kinase, rapamycin, glucose uptake, insulin sensitivity, hyperinsulinemia, hyperaminoacidemia, skeletal muscle, IRS-1 phosphorylation, endogenous glucose production, glucose turnover, insulin resistance
- MeSH terms
- Adult, Amino Acids, Biological Transport, Blood Glucose, C-Peptide, Fatty Acids, Nonesterified, Glucagon, Glucose, Humans, Insulin, Male, Protein Kinases, Reference Values, Human Growth Hormone, Sirolimus, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.